1001 PAWTUCKET BLVD., LOWELL, MA
Rapid Micro Biosystems Enters Underwriting Agreement for 3.58M Shares
Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance
Reports Second Quarter 2025 Financial Results
Team Members and Shareholders: A Personal Note from Rob
Q1
FY 2025
Q3
Q2
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Specialized Disclosure Report
Correspondence
Submission Upload